123 related articles for article (PubMed ID: 19237733)
1. Stem cells for treating glioblastoma: how close to reality?
James CD; Cavenee WK
Neuro Oncol; 2009 Apr; 11(2):101. PubMed ID: 19237733
[No Abstract] [Full Text] [Related]
2. Novel Peripherally Derived Neural-Like Stem Cells as Therapeutic Carriers for Treating Glioblastomas.
Birbrair A; Sattiraju A; Zhu D; Zulato G; Batista I; Nguyen VT; Messi ML; Solingapuram Sai KK; Marini FC; Delbono O; Mintz A
Stem Cells Transl Med; 2017 Feb; 6(2):471-481. PubMed ID: 28191774
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Combination Treatment Effect With TRAIL-secreting Mesenchymal Stem Cells and Compound C Against Glioblastoma.
Han HR; Park SA; Ahn S; Jeun SS; Ryu CH
Anticancer Res; 2019 Dec; 39(12):6635-6643. PubMed ID: 31810928
[TBL] [Abstract][Full Text] [Related]
4. Nanoparticle engineered TRAIL-overexpressing adipose-derived stem cells target and eradicate glioblastoma via intracranial delivery.
Jiang X; Fitch S; Wang C; Wilson C; Li J; Grant GA; Yang F
Proc Natl Acad Sci U S A; 2016 Nov; 113(48):13857-13862. PubMed ID: 27849590
[TBL] [Abstract][Full Text] [Related]
5. Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand.
Ehtesham M; Kabos P; Gutierrez MA; Chung NH; Griffith TS; Black KL; Yu JS
Cancer Res; 2002 Dec; 62(24):7170-4. PubMed ID: 12499252
[TBL] [Abstract][Full Text] [Related]
6. Toxin-secreting implantable therapeutic stem cells.
Gamble AJ; Boockvar JA
Neurosurgery; 2015 Apr; 76(4):N16-8. PubMed ID: 25784010
[No Abstract] [Full Text] [Related]
7. Overcoming TRAIL Resistance for Glioblastoma Treatment.
Deng L; Zhai X; Liang P; Cui H
Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33919846
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of long non-coding RNA XIST exerts tumor-suppressive functions in human glioblastoma stem cells by up-regulating miR-152.
Yao Y; Ma J; Xue Y; Wang P; Li Z; Liu J; Chen L; Xi Z; Teng H; Wang Z; Li Z; Liu Y
Cancer Lett; 2015 Apr; 359(1):75-86. PubMed ID: 25578780
[TBL] [Abstract][Full Text] [Related]
9. Identification of a novel pro-apoptotic role of NF-κB in the regulation of TRAIL- and CD95-mediated apoptosis of glioblastoma cells.
Jennewein C; Karl S; Baumann B; Micheau O; Debatin KM; Fulda S
Oncogene; 2012 Mar; 31(11):1468-74. PubMed ID: 21822306
[TBL] [Abstract][Full Text] [Related]
10. TRAIL-engineered bone marrow-derived mesenchymal stem cells: TRAIL expression and cytotoxic effects on C6 glioma cells.
Tang XJ; Lu JT; Tu HJ; Huang KM; Fu R; Cao G; Huang M; Cheng LH; Dai LJ; Zhang L
Anticancer Res; 2014 Feb; 34(2):729-34. PubMed ID: 24511006
[TBL] [Abstract][Full Text] [Related]
11. A hypoxia- and telomerase-responsive oncolytic adenovirus expressing secretable trimeric TRAIL triggers tumour-specific apoptosis and promotes viral dispersion in TRAIL-resistant glioblastoma.
Oh E; Hong J; Kwon OJ; Yun CO
Sci Rep; 2018 Jan; 8(1):1420. PubMed ID: 29362367
[TBL] [Abstract][Full Text] [Related]
12. Does the existing standard of care increase glioblastoma energy metabolism?
Seyfried TN; Shelton LM; Mukherjee P
Lancet Oncol; 2010 Sep; 11(9):811-3. PubMed ID: 20634134
[No Abstract] [Full Text] [Related]
13. Regulating the TRAIL of destruction: how A20 protects glioblastomas from TRAIL-mediated death.
Verbrugge I; Johnstone RW
Cancer Discov; 2012 Feb; 2(2):112-4. PubMed ID: 22585854
[TBL] [Abstract][Full Text] [Related]
14. Intracranial AAV-sTRAIL combined with lanatoside C prolongs survival in an orthotopic xenograft mouse model of invasive glioblastoma.
Crommentuijn MH; Maguire CA; Niers JM; Vandertop WP; Badr CE; Würdinger T; Tannous BA
Mol Oncol; 2016 Apr; 10(4):625-34. PubMed ID: 26708508
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stem cells in glioblastoma therapy and progression: How one cell does it all.
Nowak B; Rogujski P; Janowski M; Lukomska B; Andrzejewska A
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188582. PubMed ID: 34144129
[TBL] [Abstract][Full Text] [Related]
16. Stem cell-based therapies for tumors in the brain: are we there yet?
Shah K
Neuro Oncol; 2016 Aug; 18(8):1066-78. PubMed ID: 27282399
[TBL] [Abstract][Full Text] [Related]
17. Polylysine-modified polyethylenimine polymer can generate genetically engineered mesenchymal stem cells for combinational suicidal gene therapy in glioblastoma.
Malik YS; Sheikh MA; Xing Z; Guo Z; Zhu X; Tian H; Chen X
Acta Biomater; 2018 Oct; 80():144-153. PubMed ID: 30223091
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activity and prolonged expression from a TRAIL-expressing adenoviral vector.
Lee J; Hampl M; Albert P; Fine HA
Neoplasia; 2002; 4(4):312-23. PubMed ID: 12082547
[TBL] [Abstract][Full Text] [Related]
19. In vivo gene delivery by embryonic-stem-cell-derived astrocytes for malignant gliomas.
Uzzaman M; Keller G; Germano IM
Neuro Oncol; 2009 Apr; 11(2):102-8. PubMed ID: 18676359
[TBL] [Abstract][Full Text] [Related]
20. Peptide micelle-mediated delivery of tissue-specific suicide gene and combined therapy with avastin in a glioblastoma model.
Oh B; Han J; Choi E; Tan X; Lee M
J Pharm Sci; 2015 Apr; 104(4):1461-9. PubMed ID: 25631673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]